1.16.98.B1: mitochondrial amidoxime reducing component

This is an abbreviated version!
For detailed information about mitochondrial amidoxime reducing component, go to the full flat file.

Reaction

2 [Fe(II)-cytochrome b5] + 2 H+ +

Synonyms

B4114_1419, mARC1, mARC2, mitochondrial amidoxime reducing component 2, mitochondrial amidoxime-reducing component 1, Moco sulfurase C-terminal domain protein, MOSC domain-containing protein, MTARC1, MTARC2, YiiM

ECTree

     1 Oxidoreductases

         1.16 Oxidizing metal ions

             1.16.98 With other, known, physiological acceptors

                1.16.98.B1 mitochondrial amidoxime reducing component

Advanced search results

Do not include text mining results

Include results (more...)

Include results (more...)

Results	in table
3	AA Sequence
3	Cloned(Commentary)
4	Cofactor
3	Crystallization (Commentary)
31	Disease/ Diagnostics
3	General Information
14	KM Value [mM]
3	Localization
4	Metals/Ions
3	Molecular Weight [Da]
1	Natural Substrates/ Products (Substrates)
10	Organism
1	Reaction
10	Reference
5	Source Tissue
21	Specific Activity [micromol/min/mg]
19	Substrates and Products (Substrate)
5	Subunits
13	Synonyms
1	Systematic Name

Disease

topprint

print visible entries

print all entries

Disease on EC 1.16.98.B1 - mitochondrial amidoxime reducing component

Please use the Disease Search for a specific query.

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.

Please wait a moment until the data is sorted. This message will disappear when the data is sorted.

DISEASE

TITLE OF PUBLICATION

LINK TO PUBMED

Carcinoma, Hepatocellular

A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27.

32811980

Cardiovascular Diseases

A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes.

34258604

Diabetes Mellitus

A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes.

34258604

Fatty Liver

Insights into genetic variants associated with NASH-fibrosis from metabolite profiling.

32720691

Liver Diseases

A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes.

34258604

Liver Diseases

A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease.

32282858

Liver Diseases

Correction: A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease.

33822779

Liver Diseases

Insights into genetic variants associated with NASH-fibrosis from metabolite profiling.

32720691

Neoplasms

A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27.

32811980

Non-alcoholic Fatty Liver Disease

Insights into genetic variants associated with NASH-fibrosis from metabolite profiling.

32720691

Obesity

A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes.

34258604

Starvation

Molybdenum and iron mutually impact their homeostasis in cucumber (Cucumis sativus) plants.

27735062

html completed